Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index (S&P TMI). more
| Time Frame | XPH | S&P500 |
|---|---|---|
| 1-Week Return | 0.13% | -0.85% |
| 1-Month Return | 9.56% | 0.26% |
| 3-Month Return | 17.51% | 5.19% |
| 6-Month Return | 18.33% | 8.57% |
| 1-Year Return | 60.08% | 19.02% |
| 3-Year Return | 60.91% | 64.83% |
| 5-Year Return | 30.91% | 71.8% |
| 10-Year Return | 50.25% | 245.09% |
| Time Frame | XPH | S&P500 |
|---|---|---|
| 1-Week Return | 7.01% | -35.92% |
| 1-Month Return | 203.69% | 3.21% |
| 3-Month Return | 92.39% | 22.78% |
| 6-Month Return | 40.68% | 18.14% |
| 1-Year Return | 60.08% | 19.02% |
| 3-Year Return | 17.18% | 18.13% |
| 5-Year Return | 5.53% | 11.43% |
| 10-Year Return | 4.16% | 13.19% |
| Stock name | Ticker | Weight |
|---|---|---|
CRINETICS PHARMACEUTICALS IN | CRNX | 3.74% |
DEFINIUM THERAPEUTICS INC | DFTX | 2.9% |
ATAIBECKLEY INC | ATAI | 2.89% |
MBX BIOSCIENCES INC | MBX | 2.88% |
ENLIVEN THERAPEUTICS INC | ELVN | 2.1% |
ALUMIS INC | ALMS | 2.07% |
TREVI THERAPEUTICS INC | TRVI | 1.98% |
AMYLYX PHARMACEUTICALS INC | AMLX | 1.93% |
HARROW INC | HROW | 1.91% |
NUVATION BIO INC | NUVB | 1.88% |
LIGAND PHARMACEUTICALS | LGND | 1.83% |
NEKTAR THERAPEUTICS | NKTR | 1.81% |
AMNEAL PHARMACEUTICALS INC | AMRX | 1.8% |
EDGEWISE THERAPEUTICS INC | EWTX | 1.77% |
LIQUIDIA CORP | LQDA | 1.76% |
CORCEPT THERAPEUTICS INC | CORT | 1.76% |
VERADERMICS INC | MANE | 1.74% |
ELANCO ANIMAL HEALTH INC | ELAN | 1.73% |
MAZE THERAPEUTICS INC | MAZE | 1.69% |
VIATRIS INC | VTRS | 1.68% |
PACIRA BIOSCIENCES INC | PCRX | 1.67% |
BRISTOL MYERS SQUIBB CO | BMY | 1.66% |
ROYALTY PHARMA PLC CL A | RPRX | 1.64% |
MERCK + CO. INC. | MRK | 1.64% |
SUPERNUS PHARMACEUTICALS INC | SUPN | 1.63% |
INDIVIOR PHARMACEUTICALS INC | INDV | 1.63% |
EYEPOINT INC | EYPT | 1.62% |
JAZZ PHARMACEUTICALS PLC | JAZZ | 1.61% |
OCULAR THERAPEUTIX INC | OCUL | 1.6% |
JOHNSON + JOHNSON | JNJ | 1.6% |
COLLEGIUM PHARMACEUTICAL INC | COLL | 1.59% |
PRESTIGE CONSUMER HEALTHCARE | PBH | 1.57% |
ELI LILLY + CO | LLY | 1.57% |
ORGANON + CO | OGN | 1.54% |
WAVE LIFE SCIENCES LTD | WVE | 1.53% |
XERIS BIOPHARMA HOLDINGS INC | XERS | 1.53% |
ANI PHARMACEUTICALS INC | ANIP | 1.53% |
PERRIGO CO PLC | PRGO | 1.53% |
PFIZER INC | PFE | 1.5% |
INNOVIVA INC | INVA | 1.48% |
AXSOME THERAPEUTICS INC | AXSM | 1.47% |
ZOETIS INC | ZTS | 1.45% |
HARMONY BIOSCIENCES HOLDINGS | HRMY | 1.44% |
TARSUS PHARMACEUTICALS INC | TARS | 1.44% |
PHIBRO ANIMAL HEALTH CORP A | PAHC | 1.41% |
RAPPORT THERAPEUTICS INC | RAPP | 1.39% |
OMEROS CORP | OMER | 1.38% |
BIOAGE LABS INC | BIOA | 1.36% |
ETON PHARMACEUTICALS INC | ETON | 1.34% |
AMPHASTAR PHARMACEUTICALS IN | AMPH | 1.23% |
ALTO NEUROSCIENCE INC | ANRO | 1.22% |
ARVINAS INC | ARVN | 1.21% |
ZEVRA THERAPEUTICS INC | ZVRA | 1.1% |
PHATHOM PHARMACEUTICALS INC | PHAT | 1.08% |
CORMEDIX INC | CRMD | 1.07% |
THERAVANCE BIOPHARMA INC | TBPH | 0.96% |
SEPTERNA INC | SEPN | 0.93% |
ACLARIS THERAPEUTICS INC | ACRS | 0.91% |
RELMADA THERAPEUTICS INC | RLMD | 0.84% |
LB PHARMACEUTICALS INC | LBRX | 0.75% |
AQUESTIVE THERAPEUTICS INC | AQST | 0.73% |
FULCRUM THERAPEUTICS INC | FULC | 0.66% |
LEXICON PHARMACEUTICALS INC | LXRX | 0.59% |
EVOLUS INC | EOLS | 0.43% |
SSI US GOV MONEY MARKET CLASS | SSI.US.GOV.MONEY.MARKET.CLASS | 0.07% |
CONTRA ESPERION THERAP | CONTRA.ESPERION.THERAP | 0.01% |
US DOLLAR | US.DOLLAR | 0% |
| Sector | Weight |
|---|---|
|
Health care | 100.00% |
SPDR® S&P Pharmaceuticals ETF (XPH) share price today is $68.05.
Yes, Indians can buy shares of SPDR® S&P Pharmaceuticals ETF (XPH) on Vested. To buy XPH from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of SPDR® S&P Pharmaceuticals ETF (XPH) on Vested. You can start investing in SPDR® S&P Pharmaceuticals ETF (XPH) with a minimum investment of $1.
The 52-week high price of SPDR® S&P Pharmaceuticals ETF (XPH) is $70.15. The 52-week low price of SPDR® S&P Pharmaceuticals ETF (XPH) is $40.54.
The stock symbol (or ticker) of SPDR® S&P Pharmaceuticals ETF is XPH.
Yes, you can setup SIP in SPDR® S&P Pharmaceuticals ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of XPH on the Vested app.
The expense ratio of SPDR® S&P Pharmaceuticals ETF (XPH) is 0.35%.
Link copied